Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Open accessThe DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To determine factors associated with COVID-19-related death in people with rheumatic diseases. METHODS: Physician-reported registry of adults with rheumatic disease and confirmed or presumptive COVID-19 (from 24 March to 1 July 2020). The primary outcome was COVID-19-related death. Age, sex, smoking status, comorbidities, rheumatic disease diagnosis, disease activity and medications were included as covariates in multivariable logistic regression models. Analyses were further stratified according to rheumatic disease category. RESULTS: Of 3729 patients (mean age 57 years, 68% female), 390 (10.5%) died. Independent factors associated with COVID-19-related death were age (66-75 years: OR 3.00, 95% CI 2.13 to 4.22; >75 years: 6.18, 4.47 to 8.53; both vs ≤65 years), male sex (1.46, 1.11 to 1.91), hypertension combined with cardiovascular disease (1.89, 1.31 to 2.73), chronic lung disease (1.68, 1.26 to 2.25) and prednisolone-equivalent dosage >10 mg/day (1.69, 1.18 to 2.41; vs no glucocorticoid intake). Moderate/high disease activity (vs remission/low disease activity) was associated with higher odds of death (1.87, 1.27 to 2.77). Rituximab (4.04, 2.32 to 7.03), sulfasalazine (3.60, 1.66 to 7.78), immunosuppressants (azathioprine, cyclophosphamide, ciclosporin, mycophenolate or tacrolimus: 2.22, 1.43 to 3.46) and not receiving any disease-modifying anti-rheumatic drug (DMARD) (2.11, 1.48 to 3.01) were associated with higher odds of death, compared with methotrexate monotherapy. Other synthetic/biological DMARDs were not associated with COVID-19-related death. CONCLUSION: Among people with rheumatic disease, COVID-19-related death was associated with known general factors (older age, male sex and specific comorbidities) and disease-specific factors (disease activity and specific medications). The association with moderate/high disease activity highlights the importance of adequate disease control with DMARDs, preferably without increasing glucocorticoid dosages. Caution may be required with rituximab, sulfasalazine and some immunosuppressants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Previous reports have also suggested a differential association of baseline use of rheumatic disease medications on outcomes (30, 31).”
From SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis (2022) · cites this paper as [31]
In the citing paper
“Other factors such as age, sex, comorbidities, and disease activity have also been shown to influence COVID-19 outcomes in people with RMDs (31, 32).”
From SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis (2022) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simulation study of the number of events per variable in logistic regression analysis
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00236-3 · Cited by 9,655
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression
Vittinghoff, E., & McCulloch, C. E. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk052 · Cited by 4,359
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Multiple imputation of discrete and continuous data by fully conditional specification
van Buuren, S. (2007) · Statistical Methods in Medical Research · doi:10.1177/0962280206074463 · Cited by 2,827
Gianfrancesco, M., Hyrich, K. L., Al-Adely, S., Carmona, L., Danila, M. I., Gossec, L., Izadi, Z., Jacobsohn, L., Katz, P., Lawson-Tovey, S., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217871 · Cited by 1,141
Self-citationGalloway, J. B., Hyrich, K. L., Mercer, L. K., Dixon, W. G., Fu, B., Ustianowski, A. P., Watson, K. D., Lunt, M., BSRBR Control Centre Consortium, Symmons, D. P. M., et al. (2011) · Rheumatology · doi:10.1093/rheumatology/keq242 · Cited by 676
Self-citationBrenner, E. J., Ungaro, R. C., Gearry, R. B., Kaplan, G. G., Kissous-Hunt, M., Lewis, J. D., Ng, S. C., Rahier, J.-F., Reinisch, W., Ruemmele, F. M., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.032 · Cited by 674
Methotrexate an Old Drug with New Tricks
Bedoui, Y., Guillot, X., Sélambarom, J., Guiraud, P., Giry, C., Jaffar-Bandjee, M. C., Ralandison, S., & Gasque, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205023 · Cited by 471
Akiyama, S., Hamdeh, S., Micic, D., & Sakuraba, A. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218946 · Cited by 383
Research works printed but not linked: 1
- Morel, 1989, Logistic regression under complex survey designs, Surv Methodol, 15, 203
Cited by
Apostolidis, S. A., Kakara, M., Painter, M. M., Goel, R. R., Mathew, D., Lenzi, K., Rezk, A., Patterson, K. R., Espinoza, D. A., Kadri, J. C., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01507-2 · Cited by 507
Deepak, P., Kim, W., Paley, M. A., Yang, M., Carvidi, A. B., Demissie, E. G., El-Qunni, A. A., Haile, A., Huang, K., Kinnett, B., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-1757 · Cited by 418
Self-citationAging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Geisen, U. M., Berner, D. K., Tran, F., Sümbül, M., Vullriede, L., Ciripoi, M., Reid, H. M., Schaffarzyk, A., Longardt, A. C., Franzenburg, J., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220272 · Cited by 355
Henderson, L. A., Canna, S. W., Friedman, K. G., Gorelik, M., Lapidus, S. K., Bassiri, H., Behrens, E. M., Kernan, K. F., Schulert, G. S., Seo, P., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42062 · Cited by 296
Metadata
- Authors
- Strangfeld, A., Schäfer, M., Gianfrancesco, M. A., Lawson-Tovey, S., Liew, J. W., Ljung, L., Mateus, E. F., Richez, C., Santos, M. J., Schmajuk, G., Scirè, C. A., Sirotich, E., Sparks, J. A., Sufka, P., Thomas, T., Trupin, L., Wallace, Z. S., Al-Adely, S., Bachiller-Corral, J., Bhana, S., Cacoub, P., Carmona, L., Costello, R., Costello, W., Gossec, L., Grainger, R., Hachulla, E., Hasseli, R., Hausmann, J. S., Hyrich, K. L., Izadi, Z., Jacobsohn, L., Katz, P., Kearsley-Fleet, L., Robinson, P. C., Yazdany, J., & Machado, P. M.
- Affiliations
- German Rheumatism Research Centre (DE)
- University of California, San Francisco (US)
- Boston University (US)
- Karolinska Institutet (SE)
- European League Against Rheumatism (CH)
- University of Ferrara (IT)
- Canadian Arthritis Patient Alliance (CA)
- Brigham and Women's Hospital (US)
- HealthPartners (US)
- Inserm (FR)
- Harvard University (US)
- Manchester Academic Health Science Centre (GB)
- Crystal Run Healthcare (US)
- Sorbonne Université (FR)
- Instituto de Salud Musculoesquelética (ES)
- Irish Children's Arthritis Network (IE)
- University of Otago (NZ)
- Université de Lille (FR)
- Justus-Liebig-Universität Gießen (DE)
- Boston Children's Hospital (US)
- The University of Queensland (AU)
- National Health Service (GB)
- Corresponding author
- Machado, Pedro M
- ORCID
- Strangfeld, Anja
- Schäfer, Martin
- Gianfrancesco, Milena A
- Liew, Jean W
- Ljung, Lotta
- Mateus, Elsa F
- Richez, Christophe
- Santos, Maria J
- Schmajuk, Gabriela
- Scirè, Carlo A
- Sirotich, Emily
- Sparks, Jeffrey A
- Sufka, Paul
- Thomas, Thierry
- Trupin, Laura
- Wallace, Zachary S
- Al-Adely, Sarah
- Bachiller-Corral, Javier
- Bhana, Suleman
- Cacoub, Patrice
- Carmona, Loreto
- Costello, Ruth
- Gossec, Laure
- Grainger, Rebecca
- Hachulla, Eric
- Hasseli, Rebecca
- Hausmann, Jonathan S
- Hyrich, Kimme L
- Izadi, Zara
- Katz, Patricia
- Kearsley-Fleet, Lianne
- Robinson, Philip C
- Yazdany, Jinoos
- Machado, Pedro M
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 80
- Issue
- 7
- Pages
- 930-942
- ISSN
- 0003-4967 (ISSN-L)
- PMC
- PMC7843211
- OpenAlex
- W3124810175
- Cited by
- 667
- References
- 36
- Citations by year
- 2026: 16 · 2025: 36 · 2024: 87 · 2023: 136 · 2022: 174 · 2021: 217
- FWCI
- 48.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- Locations
- Annals of the Rheumatic Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, cc-by)
- Research Explorer (The University of Manchester) (publishedVersion, cc-by-nc)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
- DiVA at Umeå University (Umeå University) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- HAL (submittedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- American College of Rheumatology (NA)
- European League Against Rheumatism (NA)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- rheumatic diseases, COVID-19 mortality, risk factors, disease activity, glucocorticoids, prednisolone-equivalent dose, immunosuppressants, disease-modifying antirheumatic drugs, methotrexate, rituximab, sulfasalazine, comorbidities, chronic lung disease, hypertension
- MeSH terms
- COVID-19, SARS-CoV-2, Aged, Female, Glucocorticoids, Humans, Male, Middle Aged, Registries, Rheumatic Diseases, Rheumatology, Global Health, Comorbidity, Odds Ratio, Antirheumatic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. https://app.cochat.ai/papers/10.1136/annrheumdis-2020-219498
- The paper
- Strangfeld, A., Schäfer, M., Gianfrancesco, M. A., Lawson-Tovey, S., Liew, J. W., Ljung, L., Mateus, E. F., Richez, C., Santos, M. J., Schmajuk, G., Scirè, C. A., Sirotich, E., Sparks, J. A., Sufka, P., Thomas, T., Trupin, L., Wallace, Z. S., Al-Adely, S., Bachiller-Corral, J., . . . Machado, P. M. (2021). Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-219498
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.